Haemonetics | HAE - Current Assets


Haemonetics reported $810.83M in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Baxter International USD 6.99B 142M Jun/2026
Becton, Dickinson and Co. USD 8.14B 127M Jun/2026
Boston Scientific USD 7.97B 712M Jun/2026
Cerus USD 174.38M 7.26M Dec/2025
Cooper Companies USD 2.3B 166M Mar/2026
Fresenius EUR 11.61B 456M Jun/2026
Fresenius Medical Care EUR 7.69B 418.66M Jun/2026
Globus Medical USD 2.22B 17.39M Jun/2026
Haemonetics USD 810.83M 24.05M Jun/2026
ICU Medical USD 1.21B 2.34M Jun/2026
Intuitive Surgical USD 12.33B 807.5M Jun/2026
Medtronic USD 24.79B 716M Mar/2026
Merit Medical Systems USD 1.11B 10.46M Jun/2026
Neogen USD 604.6M 14.6M Mar/2026
OraSure Technologies USD 222.94M 17.84M Jun/2026
Plus Therapeutics USD 11.77M 6.26M Jun/2026
Quidel USD 1.38B 400K Jun/2026
ResMed USD 4.32B 260.68M Jun/2026
STAAR Surgical USD 342.35M 29.96M Jun/2026
Steris USD 2.45B 51.2M Jun/2026
Stryker USD 14.42B 1.08B Jun/2026
Teleflex USD 1.88B 16.21M Jun/2026
Terumo JPY 906.6B 45.57B Jun/2026
Thermo Fisher Scientific USD 23.36B 1.05B Jun/2026
US Physical Therapy USD 139.67M 566K Jun/2026
Zimmer Biomet Holdings USD 5.1B 134.2M Jun/2026